Natriuretic peptide receptor (NPR-A)

Class

Long-acting ANP analog

Natriuretic peptide receptor A (NPR-A), also called guanylyl cyclase A, is a cell-surface receptor found mainly in blood vessel walls, the kidney, and heart tissue. Its natural activators are atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), hormones released by the heart when chamber walls stretch under volume or pressure overload. Binding of these peptides triggers the receptor's intracellular enzyme activity, producing a signaling molecule called cyclic GMP that relaxes blood vessels, promotes salt and water excretion by the kidney, and counteracts the hormonal systems that raise blood pressure and blood volume. Because these effects lower cardiac workload and reduce fluid overload, pharmacologically sustaining this pathway is of interest in conditions such as heart failure and hypertension, where the body's own natriuretic peptides are present but rapidly broken down or cleared, limiting their benefit. Long-acting ANP analogs are engineered versions of the natural peptide modified to resist degradation and clearance, allowing more prolonged receptor engagement than the native, short-lived hormone. This approach aims to reproduce and extend the vasodilating, diuretic, and cardioprotective actions of the natural peptide system rather than to introduce an entirely new mechanism.